Moreover, LUAD patients were sub-grouped into 4 groups by their PD-L1 and MUC3A expression levels, and the increased MUC3A and PD-L1 levels were correlated with increased lymph node metastasis (p < 0.05, Table 1). This evidence concerns the gene MUC3A and metastatic malignant neoplasm in the lymph nodes.